Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial (Cancer Immunology, Immunotherapy, (2019), 10.1007/s00262-019-02320-0)

Autor: Koster, Bas D., Santegoets, Saskia J. A. M., Harting, Jorien, Baars, Arnold, van Ham, S. Marieke, Scheper, Rik J., Hooijberg, Erik, de Gruijl, Tanja D., van den Eertwegh, Alfons J. M.

Publikováno v: Koster, B D, Santegoets, S J A M, Harting, J, Baars, A, van Ham, S M, Scheper, R J, Hooijberg, E, de Gruijl, T D & van den Eertwegh, A J M 2019, ' Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial (Cancer Immunology, Immunotherapy, (2019), 10.1007/s00262-019-02320-0) ', Cancer Immunology, Immunotherapy, vol. 68, no. 6, pp. 1037 . https://doi.org/10.1007/s00262-019-02328-6

In the original publication of the article the following abstract and keywords were inadvertently omitted. Abstract Background In this study the toxicity and efficacy of an irradiated autologous tumor cell vaccine (ATV) co-injected with a class-B CpG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::04ecbe5a6f598bb59c77abea36bf59c9
https://research.vumc.nl/en/publications/81eff464-4904-46c0-b540-ea1aa0efb842

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Autor: Koster, Bas D., Santegoets, Saskia J. A. M., Harting, Jorien, Baars, Arnold, van Ham, S. Marieke, Scheper, Rik J., Hooijberg, Erik, de Gruijl, Tanja D., van den Eertwegh, Alfons J. M.

Publikováno v: Cancer Immunology, Immunotherapy; Jun2019, Vol. 68 Issue 6, p1025-1035, 11p